Healthcare & Life Sciences
Fore Biotherapeutics
United Statesfore.bio
Fore Biotherapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C, 2 tracked investors.
Activeseries-c
series-c
Stage
2017
Founded
2
Investors
About Fore Biotherapeutics
Fore Biotherapeutics is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series C. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Fore Biotherapeutics is a virtual biotechnology company developing plixorafenib, a next-generation BRAF inhibitor in global Phase 2 trials intended to treat advanced solid tumors with BRAF alterations.
Explore Fore Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.